364 related articles for article (PubMed ID: 29601787)
1. Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.
Mattsson N; Groot C; Jansen WJ; Landau SM; Villemagne VL; Engelborghs S; Mintun MM; Lleo A; Molinuevo JL; Jagust WJ; Frisoni GB; Ivanoiu A; Chételat G; Resende de Oliveira C; Rodrigue KM; Kornhuber J; Wallin A; Klimkowicz-Mrowiec A; Kandimalla R; Popp J; Aalten PP; Aarsland D; Alcolea D; Almdahl IS; Baldeiras I; van Buchem MA; Cavedo E; Chen K; Cohen AD; Förster S; Fortea J; Frederiksen KS; Freund-Levi Y; Gill KD; Gkatzima O; Grimmer T; Hampel H; Herukka SK; Johannsen P; van Laere K; de Leon MJ; Maier W; Marcusson J; Meulenbroek O; Møllergård HM; Morris JC; Mroczko B; Nordlund A; Prabhakar S; Peters O; Rami L; Rodríguez-Rodríguez E; Roe CM; Rüther E; Santana I; Schröder J; Seo SW; Soininen H; Spiru L; Stomrud E; Struyfs H; Teunissen CE; Verhey FRJ; Vos SJB; van Waalwijk van Doorn LJC; Waldemar G; Wallin ÅK; Wiltfang J; Vandenberghe R; Brooks DJ; Fladby T; Rowe CC; Drzezga A; Verbeek MM; Sarazin M; Wolk DA; Fleisher AS; Klunk WE; Na DL; Sánchez-Juan P; Lee DY; Nordberg A; Tsolaki M; Camus V; Rinne JO; Fagan AM; Zetterberg H; Blennow K; Rabinovici GD; Hansson O; van Berckel BNM; van der Flier WM; Scheltens P; Visser PJ; Ossenkoppele R
Alzheimers Dement; 2018 Jul; 14(7):913-924. PubMed ID: 29601787
[TBL] [Abstract][Full Text] [Related]
2. Discordant amyloid-β PET and CSF biomarkers and its clinical consequences.
de Wilde A; Reimand J; Teunissen CE; Zwan M; Windhorst AD; Boellaard R; van der Flier WM; Scheltens P; van Berckel BNM; Bouwman F; Ossenkoppele R
Alzheimers Res Ther; 2019 Sep; 11(1):78. PubMed ID: 31511058
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
4. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
[TBL] [Abstract][Full Text] [Related]
5. Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts.
Buckley RF; Mormino EC; Amariglio RE; Properzi MJ; Rabin JS; Lim YY; Papp KV; Jacobs HIL; Burnham S; Hanseeuw BJ; Doré V; Dobson A; Masters CL; Waller M; Rowe CC; Maruff P; Donohue MC; Rentz DM; Kirn D; Hedden T; Chhatwal J; Schultz AP; Johnson KA; Villemagne VL; Sperling RA; ; ;
Alzheimers Dement; 2018 Sep; 14(9):1193-1203. PubMed ID: 29803541
[TBL] [Abstract][Full Text] [Related]
6. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment.
Insel PS; Hansson O; Mattsson-Carlgren N
JAMA Neurol; 2021 Feb; 78(2):229-235. PubMed ID: 33044487
[TBL] [Abstract][Full Text] [Related]
7. Effect of APOE ε4 genotype on amyloid-β, glucose metabolism, and gray matter volume in cognitively normal individuals and amnestic mild cognitive impairment.
Li W; Li R; Yan S; Zhao Z; Shan Y; Qi Z; Lu J;
Eur J Neurol; 2023 Mar; 30(3):587-596. PubMed ID: 36448771
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E ε4 and ε3 alleles associate with cerebrospinal fluid tau and cognition in the presence of amyloid-β in mild cognitive impairment but not in Alzheimer's disease.
Xing F; Meng T; Therriault J; Luo J; Zhang H;
J Integr Neurosci; 2021 Jun; 20(2):277-286. PubMed ID: 34258926
[TBL] [Abstract][Full Text] [Related]
9. Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease.
Lim YY; Kalinowski P; Pietrzak RH; Laws SM; Burnham SC; Ames D; Villemagne VL; Fowler CJ; Rainey-Smith SR; Martins RN; Rowe CC; Masters CL; Maruff PT
JAMA Neurol; 2018 Apr; 75(4):488-494. PubMed ID: 29356823
[TBL] [Abstract][Full Text] [Related]
10. The Role of Apolipoprotein E ε4 in Early and Late Mild Cognitive Impairment.
Luo Y; Tan L; Therriault J; Zhang H; Gao Y;
Eur Neurol; 2021; 84(6):472-480. PubMed ID: 34340229
[TBL] [Abstract][Full Text] [Related]
11. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
[TBL] [Abstract][Full Text] [Related]
12. APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly.
Snellman A; Ekblad LL; Tuisku J; Koivumäki M; Ashton NJ; Lantero-Rodriguez J; Karikari TK; Helin S; Bucci M; Löyttyniemi E; Parkkola R; Karrasch M; Schöll M; Zetterberg H; Blennow K; Rinne JO
Alzheimers Res Ther; 2023 Apr; 15(1):71. PubMed ID: 37016464
[TBL] [Abstract][Full Text] [Related]
13. Differential Effects of the Interaction Between the Education and APOE ε4 Allele on Amyloid-beta Retention and Memory Performances in Cognitively Normal Older Adults and Alzheimer's Disease Patients.
Kang DW; Wang SM; Na HR; Lee CU; Baek IH; Lim HK
Curr Alzheimer Res; 2020; 17(11):1023-1032. PubMed ID: 33372875
[TBL] [Abstract][Full Text] [Related]
14. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
Smith R; Strandberg O; Mattsson-Carlgren N; Leuzy A; Palmqvist S; Pontecorvo MJ; Devous MD; Ossenkoppele R; Hansson O
Brain; 2020 Dec; 143(12):3805-3815. PubMed ID: 33439987
[TBL] [Abstract][Full Text] [Related]
15. APOE ε4 is associated with higher levels of CSF SNAP-25 in prodromal Alzheimer's disease.
Wang S; Zhang J; Pan T;
Neurosci Lett; 2018 Oct; 685():109-113. PubMed ID: 30144541
[TBL] [Abstract][Full Text] [Related]
16. Klotho allele status is not associated with Aβ and APOE ε4-related cognitive decline in preclinical Alzheimer's disease.
Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Ames D; Masters CL; Martins RN; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM
Neurobiol Aging; 2019 Apr; 76():162-165. PubMed ID: 30716541
[TBL] [Abstract][Full Text] [Related]
17. Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex,
Therriault J; Pascoal TA; Benedet AL; Tissot C; Savard M; Chamoun M; Lussier F; Kang MS; Berzgin G; Wang T; Fernandes-Arias J; Massarweh G; Soucy JP; Vitali P; Saha-Chaudhuri P; Gauthier S; Rosa-Neto P
Neurology; 2021 Feb; 96(7):e975-e985. PubMed ID: 33443136
[TBL] [Abstract][Full Text] [Related]
18. Aβ-related memory decline in APOE ε4 noncarriers: Implications for Alzheimer disease.
Lim YY; Laws SM; Villemagne VL; Pietrzak RH; Porter T; Ames D; Fowler C; Rainey-Smith S; Snyder PJ; Martins RN; Salvado O; Bourgeat P; Rowe CC; Masters CL; Maruff P
Neurology; 2016 Apr; 86(17):1635-42. PubMed ID: 27029632
[TBL] [Abstract][Full Text] [Related]
19. APOE ε4 is associated with decreased synaptic density in cognitively impaired participants.
He K; Li B; Wang J; Wang Y; You Z; Chen X; Chen H; Li J; Huang Q; Guo Q; Huang YH; Guan Y; Chen K; Zhao J; Deng Y; Xie F
Alzheimers Dement; 2024 May; 20(5):3157-3166. PubMed ID: 38477490
[TBL] [Abstract][Full Text] [Related]
20. Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease.
Reiman EM; Chen K; Liu X; Bandy D; Yu M; Lee W; Ayutyanont N; Keppler J; Reeder SA; Langbaum JB; Alexander GE; Klunk WE; Mathis CA; Price JC; Aizenstein HJ; DeKosky ST; Caselli RJ
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6820-5. PubMed ID: 19346482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
